The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Stroke Volume

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Stroke Volume


Psychiatry related information on Stroke Volume


High impact information on Stroke Volume


Chemical compound and disease context of Stroke Volume


Biological context of Stroke Volume


Anatomical context of Stroke Volume


Associations of Stroke Volume with chemical compounds


Gene context of Stroke Volume


Analytical, diagnostic and therapeutic context of Stroke Volume


  1. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. Alexander, J., Dainiak, N., Berger, H.J., Goldman, L., Johnstone, D., Reduto, L., Duffy, T., Schwartz, P., Gottschalk, A., Zaret, B.L. N. Engl. J. Med. (1979) [Pubmed]
  2. Ventricular dysfunction and the risk of stroke after myocardial infarction. Loh, E., Sutton, M.S., Wun, C.C., Rouleau, J.L., Flaker, G.C., Gottlieb, S.S., Lamas, G.A., Moyé, L.A., Goldhaber, S.Z., Pfeffer, M.A. N. Engl. J. Med. (1997) [Pubmed]
  3. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh, S.N., Fletcher, R.D., Fisher, S.G., Singh, B.N., Lewis, H.D., Deedwania, P.C., Massie, B.M., Colling, C., Lazzeri, D. N. Engl. J. Med. (1995) [Pubmed]
  4. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. Gottlieb, S.S., McCarter, R.J., Vogel, R.A. N. Engl. J. Med. (1998) [Pubmed]
  5. The effect of terbutaline on cardiac function in patients with stable chronic obstructive lung disease. Sunderrajan, E.V., Byron, W.A., McKenzie, W.N., Hurst, D.J., Allegro, M.M., Thakur, V.M., Holmes, R.A. JAMA (1983) [Pubmed]
  6. Perspectives on exercise and wasting. Buskirk, E.R. J. Nutr. (1999) [Pubmed]
  7. Cardiovascular changes associated with obstructive sleep apnea syndrome. Stoohs, R., Guilleminault, C. J. Appl. Physiol. (1992) [Pubmed]
  8. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. Yancy, C.W., Fowler, M.B., Colucci, W.S., Gilbert, E.M., Bristow, M.R., Cohn, J.N., Lukas, M.A., Young, S.T., Packer, M. N. Engl. J. Med. (2001) [Pubmed]
  9. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J., Wittes, J. N. Engl. J. Med. (1999) [Pubmed]
  10. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. Pacifico, A., Hohnloser, S.H., Williams, J.H., Tao, B., Saksena, S., Henry, P.D., Prystowsky, E.N. N. Engl. J. Med. (1999) [Pubmed]
  11. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R.C., Wright, R. N. Engl. J. Med. (1989) [Pubmed]
  12. Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure. Schiffrin, E.L., Taillefer, R. N. Engl. J. Med. (1986) [Pubmed]
  13. Effect of digoxin on right ventricular function in severe chronic airflow obstruction. A controlled clinical trial. Mathur, P.N., Powles, P., Pugsley, S.O., McEwan, M.P., Campbell, E.J. Ann. Intern. Med. (1981) [Pubmed]
  14. Significance of a negative exercise thallium test in the presence of a critical residual stenosis after thrombolysis for acute myocardial infarction. Sutton, J.M., Topol, E.J. Circulation (1991) [Pubmed]
  15. Maintained stroke volume but impaired arterial oxygenation in man at high altitude with supplemental CO2. Grover, R.F., Reeves, J.T., Maher, J.T., McCullough, R.E., Cruz, J.C., Denniston, J.C., Cymerman, A. Circ. Res. (1976) [Pubmed]
  16. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. Williams, M.J., Odabashian, J., Lauer, M.S., Thomas, J.D., Marwick, T.H. J. Am. Coll. Cardiol. (1996) [Pubmed]
  17. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. Gottlieb, S.S., Kukin, M.L., Ahern, D., Packer, M. J. Am. Coll. Cardiol. (1989) [Pubmed]
  18. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. Sevransky, J.E., Shaked, G., Novogrodsky, A., Levitzki, A., Gazit, A., Hoffman, A., Elin, R.J., Quezado, Z.M., Freeman, B.D., Eichacker, P.Q., Danner, R.L., Banks, S.M., Bacher, J., Thomas, M.L., Natanson, C. J. Clin. Invest. (1997) [Pubmed]
  19. Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning. Sullivan, M.J., Binkley, P.F., Unverferth, D.V., Ren, J.H., Boudoulas, H., Bashore, T.M., Merola, A.J., Leier, C.V. J. Clin. Invest. (1985) [Pubmed]
  20. Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive. Corin, W.J., Swindle, M.M., Spann, J.F., Nakano, K., Frankis, M., Biederman, R.W., Smith, A., Taylor, A., Carabello, B.A. J. Clin. Invest. (1988) [Pubmed]
  21. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Chatterjee, K., Ports, T.A., Brundage, B.H., Massie, B., Holly, A.N., Parmley, W.W. Ann. Intern. Med. (1980) [Pubmed]
  22. Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions. Evidence for a central sympatholytic action. Kooner, J.S., Birch, R., Frankel, H.L., Peart, W.S., Mathias, C.J. Circulation (1991) [Pubmed]
  23. Assessment of cardiac performance with quantitative radionuclide angiocardiography. Effects of oral propranolol on global and regional left ventricular function in coronary artery disease. Marshall, R.C., Berger, H.J., Reduto, L.A., Cohen, L.S., Gottschalk, A., Zaret, B.L. Circulation (1978) [Pubmed]
  24. Captopril in primary pulmonary hypertension. Leier, C.V., Bambach, D., Nelson, S., Hermiller, J.B., Huss, P., Magorien, R.D., Unverferth, D.V. Circulation (1983) [Pubmed]
  25. Echocardiographic study of the paradoxical arterial pulse in chronic obstructive lung disease. Settle, H.P., Engel, P.J., Fowler, N.O., Allen, J.M., Vassallo, C.L., Hackworth, J.N., Adolph, R.J., Eppert, D.C. Circulation (1980) [Pubmed]
  26. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Liu, D., Wu, L., Breyer, R., Mattson, M.P., Andreasson, K. Ann. Neurol. (2005) [Pubmed]
  27. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. Malouf, J.F., Enriquez-Sarano, M., Pellikka, P.A., Oh, J.K., Bailey, K.R., Chandrasekaran, K., Mullany, C.J., Tajik, A.J. J. Am. Coll. Cardiol. (2002) [Pubmed]
  28. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. Roberts, R., Croft, C., Gold, H.K., Hartwell, T.D., Jaffe, A.S., Muller, J.E., Mullin, S.M., Parker, C., Passamani, E.R., Poole, W.K. N. Engl. J. Med. (1984) [Pubmed]
  29. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. Follansbee, W.P., Curtiss, E.I., Medsger, T.A., Steen, V.D., Uretsky, B.F., Owens, G.R., Rodnan, G.P. N. Engl. J. Med. (1984) [Pubmed]
  30. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn, J.N., Archibald, D.G., Ziesche, S., Franciosa, J.A., Harston, W.E., Tristani, F.E., Dunkman, W.B., Jacobs, W., Francis, G.S., Flohr, K.H. N. Engl. J. Med. (1986) [Pubmed]
  31. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. Ferguson, T.B., Coombs, L.P., Peterson, E.D. JAMA (2002) [Pubmed]
  32. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study. Cowan, J.D., Neidhart, J., McClure, S., Coltman, C.A., Gumbart, C., Martino, S., Hutchins, L.F., Stephens, R.L., Vaughan, C.B., Osborne, C.K. J. Natl. Cancer Inst. (1991) [Pubmed]
  33. Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure. Yamazaki, T., Lee, J.D., Shimizu, H., Uzui, H., Ueda, T. Eur. J. Heart Fail. (2004) [Pubmed]
  34. Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors. Rebello, S., Roy, S., Saxena, P.R., Gulati, A. Brain Res. (1995) [Pubmed]
  35. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Nagaya, N., Kojima, M., Uematsu, M., Yamagishi, M., Hosoda, H., Oya, H., Hayashi, Y., Kangawa, K. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2001) [Pubmed]
  36. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Satoh, M., Nakamura, M., Saitoh, H., Satoh, H., Akatsu, T., Iwasaka, J., Masuda, T., Hiramori, K. Clin. Sci. (2002) [Pubmed]
  37. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. Parissis, J.T., Adamopoulos, S., Venetsanou, K.F., Mentzikof, D.G., Karas, S.M., Kremastinos, D.T. J. Interferon Cytokine Res. (2002) [Pubmed]
  38. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. Baim, D.S., McDowell, A.V., Cherniles, J., Monrad, E.S., Parker, J.A., Edelson, J., Braunwald, E., Grossman, W. N. Engl. J. Med. (1983) [Pubmed]
  39. Negative effects of famotidine on cardiac performance assessed by noninvasive hemodynamic measurements. Kirch, W., Halabi, A., Linde, M., Santos, S.R., Ohnhaus, E.E. Gastroenterology (1989) [Pubmed]
  40. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Chanson, P., Timsit, J., Masquet, C., Warnet, A., Guillausseau, P.J., Birman, P., Harris, A.G., Lubetzki, J. Ann. Intern. Med. (1990) [Pubmed]
  41. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Greenberg, B., Massie, B., Bristow, J.D., Cheitlin, M., Siemienczuk, D., Topic, N., Wilson, R.A., Szlachcic, J., Thomas, D. Circulation (1988) [Pubmed]
  42. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Maturi, M.F., Martin, S.E., Markle, D., Maxwell, M., Burruss, C.R., Speir, E., Greene, R., Ro, Y.M., Vitale, D., Green, M.V. Circulation (1991) [Pubmed]
WikiGenes - Universities